Toxic cyanobacterial bloom problems in Australian waters: Risks and impacts on human health

Phycologia

Volumn 40, Issue 3, 2001, Pages 228-233

  Falconer, I R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034874474     PISSN: 00318884     EISSN: None     Source Type: Journal    
DOI: 10.2216/i0031-8884-40-3-228.1     Document Type: Article

References (45)

1. An outbreak of hepato-enteritis (the Palm Island Mystery Disease) possibly caused by algal intoxication
2. Palm Island mystery disease
3. Palm Island mystery disease
4. A biochemical profile for predicting the chronic exposure of sheep to Microcystis aeruginosa, an hepatotoxic species of blue-green alga
5. Recovery of hepatic function and latent mortalities in sheep exposed to the blue-green alga Microcystis aeruginosa
6. Catalogue of risks extended and updated
7. A model system for studying the bioavailability of intestinally administered microcystin-LR, a hepatotoxic peptide from the cyanobacterium Microcystis aeruginosa
8. Murray River water, raised cyanobacterial cell counts, and gastro-intestinal and dermatological symptoms
9. Tumour promotion by cyanobacterial toxins
10. Evidence of liver damage by toxin from a bloom of the blue-green alga, Microcystis aeruginosa
11. Oral toxicity of a bloom of the cyanobacterium Microcystis aeruginosa administered to mice over periods up to 1 year
12. Use of powdered and granular activated carbon to remove toxicity from drinking water containing cyanobacterial toxins
13. Toxicity of edible mussels (Mytilus edulis) growing naturally in an estuary during a water bloom of the blue-green alga Nodularia spumigena
14. Effect of the cyanobacterial (blue-green algal) toxins from the Microcystis aeruginosa on isolated enterocytes from the chicken small intestine
15. Toxicity of the blue-green alga (cyanobacterium) Microcystis aeruginosa in drinking water to growing pigs, as an animal model for human injury and risk assessment
16. Safe levels and safe practices
17. Hepatic and renal toxicity of the blue-green alga (cyanobacterium) Cylindrospermopsis raciborskii in male Swiss Albino mice
18. Development of health alerts for cyanobacteria and related toxins in drinking-water in South Australia
19. Poisonous Australian lake
20. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds
21. Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Wołoszyńska) Seenaya and Subba Raju isolated form a domestic supply reservoir
22. The effect of the Dawesville Channel on cyanobacterial blooms and associated phytoplankton in the eutrophic Peel-Harvey Estuary and its associated waterways, Mandurah, Western Australia
23. Remedial measures
24. Microcystin-LR and liver tumour promotion: Effects on cytokinesis, ploidy and apoptosis in cultured hepatocytes
25. Microcystins (cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse colon
26. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR
27. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil
28. A toxic bloom of Nodularia spumigena Mertens in Orielton Lagoon, Tasmania
29. Human health aspects
30. Nodularin, a potent inhibitor of protein phosphatases 1 and 2a, is a new environmental carcinogen in male f344 rat liver
31. Cylindrospermopsin: A potent hepatotoxin from the blue-green alga Cylindrospermopsis raciborskii
32. Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities
33. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil
34. The oral toxicity of the tropical cyanobacterium Cylindrospermopsis raciborskii (Wołoszyńska)
35. Cyanobacterial toxins
36. Gastroenteritis epidemic in the area of the Itaparica Dam, Bahia, Brasil
37. Pneumonia associated with contact with cyanobacteria
38. Drinking water and primary liver cancer
39. Primary prevention of hepatocellular carcinoma